Mark Adams - Nu Skin Chief Officer
| NUS Stock | USD 8.18 0.02 0.25% |
Executive
Mark Adams is Chief Officer of Nu Skin Enterprises
| Age | 73 |
| Address | 75 West Center Street, Provo, UT, United States, 84601 |
| Phone | 801 345 1000 |
| Web | https://www.nuskin.com |
Mark Adams Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Adams against Nu Skin stock is an integral part of due diligence when investing in Nu Skin. Mark Adams insider activity provides valuable insight into whether Nu Skin is net buyers or sellers over its current business cycle. Note, Nu Skin insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nu Skin'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Adams over three months ago Disposition of 125000 shares by Mark Adams of Penguin Solutions, subject to Rule 16b-3 | ||
Mark Adams over six months ago Disposition of 6995 shares by Mark Adams of Smart Global at 23.86 subject to Rule 16b-3 |
Nu Skin Management Efficiency
The company has Return on Asset of 0.0342 % which means that on every $100 spent on assets, it made $0.0342 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.199) %, meaning that it generated no profit with money invested by stockholders. Nu Skin's management efficiency ratios could be used to measure how well Nu Skin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.11 in 2025. Return On Capital Employed is likely to gain to -0.12 in 2025. At this time, Nu Skin's Total Current Assets are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 83 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 621.2 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MD MBA | Herbalife Nutrition | N/A | |
| Eric Jacobson | Flowers Foods | N/A | |
| Ibelis Montesino | Herbalife Nutrition | 61 | |
| Kathryn Armstrong | USANA Health Sciences | 44 | |
| Dr MNS | USANA Health Sciences | 60 | |
| Troy Hicks | Herbalife Nutrition | 47 | |
| Qun Zheng | Herbalife Nutrition | 67 | |
| Stephanie JD | Flowers Foods | 54 | |
| Ashley Collins | USANA Health Sciences | N/A | |
| Andrew JD | Herbalife Nutrition | N/A | |
| Joshua JD | USANA Health Sciences | 49 | |
| John Cuomo | USANA Health Sciences | N/A | |
| Daniel Macuga | USANA Health Sciences | 55 | |
| Sherman Ying | USANA Health Sciences | N/A | |
| Andrew Williams | Polaris Industries | N/A | |
| Debo Mukherjee | Flowers Foods | 56 | |
| Douglas Hekking | USANA Health Sciences | 55 | |
| Mary Krier | Flowers Foods | N/A | |
| Patrique Richards | USANA Health Sciences | N/A | |
| Joshua Foukas | USANA Health Sciences | 48 | |
| Bill Ferrante | Herbalife Nutrition | N/A | |
Management Performance
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0342 |
Nu Skin Enterprises Leadership Team
Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUS. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Pond, Director - Investor Relations | ||
| Ritch Wood, CFO, Principal Accounting Officer and VP | ||
| Chayce Clark, Executive Vice President General Counsel | ||
| Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer | ||
| Ruth Todd, Senior Officer | ||
| Emma Battle, Director | ||
| Thomas Pisano, Independent Director | ||
| Mark Adams, Chief Officer | ||
| Zheqing Shen, Independent Director | ||
| James Thomas, Chief Accounting Officer | ||
| Mang Tang, Strategic Advisor | ||
| Joe Sueper, Senior CTO | ||
| Steven Hatchett, Executive Officer | ||
| Mark Lawrence, Chief Financial Officer, Executive Vice President | ||
| Sandra Tillotson, Founder | ||
| D Dorny, Executive Vice President, General Counsel, Secretary | ||
| Steve Hatchett, Executive Officer | ||
| Daniel Campbell, Lead Independent Director | ||
| Edwina Woodbury, Independent Director | ||
| Laura Nathanson, Independent Director | ||
| Steven Lund, Executive Chairman of the Board | ||
| Matthew Dorny, VP, General Counsel and Secretary | ||
| Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer | ||
| Justin Keisel, President Americas | ||
| Blake Roney, Founder | ||
| Steven JD, CoFounder Board | ||
| Andrew Lipman, Independent Director | ||
| Greg Belliston, Assistant Secretary | ||
| Ashok Pahwa, Chief Officer | ||
| Ryan Napierski, President, Chief Executive Officer, Director |
NUS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0342 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 685.97 M | ||||
| Shares Outstanding | 49.72 M | ||||
| Shares Owned By Insiders | 3.41 % | ||||
| Shares Owned By Institutions | 77.58 % | ||||
| Number Of Shares Shorted | 2.19 M | ||||
| Price To Earning | 10.70 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.